NCT04081688 2026-02-05
Atezolizumab and Varlilumab in Combination With Radiation Therapy for NSCLC
Rutgers, The State University of New Jersey
Phase 1 Terminated
Rutgers, The State University of New Jersey
Kezar Life Sciences, Inc.
Ascentage Pharma Group Inc.